![]() |
Volumn 18, Issue 1, 2012, Pages 11-
|
Glioblastoma multiforme-new approaches to therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
DENDRITIC CELL VACCINE;
IMMUNOMODULATING AGENT;
NANOPARTICLE;
ONCOLYTIC VIRUS;
VIRUS VECTOR;
ANGIOGENESIS;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CANCER RELAPSE;
CANCER THERAPY;
CLINICAL TRIAL (TOPIC);
COHORT ANALYSIS;
DATA PROCESSING;
DIAGNOSTIC PROCEDURE;
DRUG SAFETY;
DRUG TRANSFORMATION;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GLIOBLASTOMA;
HEALTH CARE DELIVERY;
HUMAN;
MEDICAL EXPERT;
MEDICAL LITERATURE;
MOLECULAR PATHOLOGY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
BRAIN NEOPLASMS;
COMBINED MODALITY THERAPY;
GLIOBLASTOMA;
HUMANS;
|
EID: 84856739011
PISSN: 15289117
EISSN: 1540336X
Source Type: Journal
DOI: 10.1097/PPO.0b013e318249ccbe Document Type: Editorial |
Times cited : (2)
|
References (0)
|